Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY

v3.21.2
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Cumulative Effect, Period of Adoption, Adjustment
Legacy Convertible Preferred Stock
Cumulative Effect, Period of Adoption, Adjustment
Common Stock
Cumulative Effect, Period of Adoption, Adjustment
Additional Paid-In Capital
Cumulative Effect, Period of Adoption, Adjustment
Cumulative Effect, Period of Adoption, Adjusted Balance
Common Stock
Cumulative Effect, Period of Adoption, Adjusted Balance
Additional Paid-In Capital
Cumulative Effect, Period of Adoption, Adjusted Balance
Accumulated Deficit
Cumulative Effect, Period of Adoption, Adjusted Balance
Accumulated Other Comprehensive (Loss) Income
Cumulative Effect, Period of Adoption, Adjusted Balance
Legacy Convertible Preferred Stock
Common Stock
In-process research and development
Common Stock
Additional Paid-In Capital
In-process research and development
Additional Paid-In Capital
Accumulated Deficit
Accumulated Other Comprehensive (Loss) Income
In-process research and development
Total
BALANCE at Dec. 31, 2019 $ (436,533)                 $ 436,533                
BALANCE (in shares) at Dec. 31, 2019 (100,038,109)                 100,038,109                
BALANCE at Dec. 31, 2019   $ 13 $ 436,520 $ 436,533 $ 16 $ 453,242 $ (294,262) $ 75 $ 159,071     $ 3   $ 16,722 $ (294,262) $ 75   $ (277,462)
BALANCE (in shares) at Dec. 31, 2019   128,100,821     154,913,934             26,813,113            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                    
Exercise of Common Stock options                           267       267
Exercise of Common Stock options (in shares)                       499,256            
Vesting of restricted Common Stock                           6       6
Vesting of restricted stock units (in shares)                       5,252,279            
Stock-based compensation expense                           4,228       4,228
Common Stock warrants issued                           211       211
Net loss                             (65,027)     (65,027)
Other comprehensive income (loss)                               (70)   (70)
BALANCE at Sep. 30, 2020                       $ 16   457,954 (359,289) 5   98,686
BALANCE (in shares) at Sep. 30, 2020                       160,665,469            
BALANCE at Jun. 30, 2020 $ (436,533)                 $ 436,533                
BALANCE (in shares) at Jun. 30, 2020 (100,038,109)                 100,038,109                
BALANCE at Jun. 30, 2020   $ 13 $ 434,672 $ 434,685 $ 16 $ 455,926 $ (339,832) $ 48 $ 116,158     $ 3   21,254 (339,832) 48   (318,527)
BALANCE (in shares) at Jun. 30, 2020   128,792,027     158,729,658             29,937,631            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                    
Exercise of Common Stock options                           131       131
Exercise of Common Stock options (in shares)                       184,447            
Vesting of restricted Common Stock                           2       2
Vesting of restricted Common Stock (in shares)                       1,751,364            
Stock-based compensation expense                           1,895       1,895
Net loss                             (19,457)     (19,457)
Other comprehensive income (loss)                               (43)   (43)
BALANCE at Sep. 30, 2020                       $ 16   457,954 (359,289) 5   98,686
BALANCE (in shares) at Sep. 30, 2020                       160,665,469            
BALANCE at Dec. 31, 2020                       $ 23   844,188 (328,277) (9)   515,925
BALANCE (in shares) at Dec. 31, 2020                       224,626,597            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                    
Exercise of Common Stock options                           5,241       5,241
Exercise of Common Stock options (in shares)                       4,462,218            
Vesting of restricted Common Stock (in shares)                       407,629            
Vesting of restricted stock units (in shares)                       303,656            
Net share settlement related to employee tax withholdings upon vesting of restricted stock units                           (454)       (454)
Net share settlement related to employee tax withholdings upon vesting of restricted stock units (in shares)                       (49,471)            
Issuance of Common Stock for acquisitions                       $ 1   208,988       208,989
Issuance of Common Stock for acquisitions (in shares)                       9,049,338            
Issuance of common stock for acquired in-process research and development                         $ 4,300       $ 4,300  
Issuance of common stock for acquired in-process research and development (in shares)                     334,370              
Repurchase of Common Stock                           (958)       (958)
Repurchase of Common Stock (in shares)                       (109,150)            
Stock-based compensation expense                           16,167       16,167
Vesting of Trine Founder shares (in shares)                       1,850,938            
Exercise of warrants                       $ 2   320,567       320,569
Exercise of warrants (in shares)                       20,690,975            
Net loss                             (169,167)     (169,167)
Other comprehensive income (loss)                               (1,110)   (1,110)
BALANCE at Sep. 30, 2021                       $ 26   1,398,039 (497,444) (1,119)   899,502
BALANCE (in shares) at Sep. 30, 2021                       261,567,100            
BALANCE at Jun. 30, 2021                       $ 26   1,387,779 (430,565) 104   957,344
BALANCE (in shares) at Jun. 30, 2021                       259,545,731            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                    
Exercise of Common Stock options                           1,576       1,576
Exercise of Common Stock options (in shares)                       1,615,484            
Vesting of restricted Common Stock (in shares)                       295,599            
Vesting of restricted stock units (in shares)                       259,735            
Net share settlement related to employee tax withholdings upon vesting of restricted stock units                           (309)       (309)
Net share settlement related to employee tax withholdings upon vesting of restricted stock units (in shares)                       (40,299)            
Repurchase of Common Stock                           (958)       (958)
Repurchase of Common Stock (in shares)                       (109,150)            
Stock-based compensation expense                           9,951       9,951
Net loss                             (66,879)     (66,879)
Other comprehensive income (loss)                               (1,223)   (1,223)
BALANCE at Sep. 30, 2021                       $ 26   $ 1,398,039 $ (497,444) $ (1,119)   $ 899,502
BALANCE (in shares) at Sep. 30, 2021                       261,567,100